BCAX

Bicara Therapeutics Inc. Common Stock (BCAX)

US
$ 00%

Price Chart

Key Statistics

Market Cap
$ 651.48M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
0
52W High
$ 28.09
52W Low
$ 7.80
Dividend Yield
0.00%
Beta
0.00

Technicals

50-Day MA
10.646
200-Day MA
13.3989
52 Week High
28.09
52 Week Low
7.8

About BCAX

Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors.

Employees
55
Headquarters
Boston, MA
CEO
Dr. Claire Mazumdar Clemon M.B.A., Ph.D.

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg